Ishani Areef, Solid Craig A, Weinhandl Eric D, Gilbertson David T, Foley Robert N, Collins Allan J
Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S-253, Minneapolis, MN 55404, USA.
Nephrol Dial Transplant. 2008 May;23(5):1682-9. doi: 10.1093/ndt/gfm845. Epub 2007 Dec 8.
A proportion of haemodialysis patients experience periods below target haemoglobin levels due to longer time required to reach the target or to haemoglobin level variability. We aimed to determine the consequences associated with cumulative number of months below target haemoglobin concentrations.
We constructed an incident cohort including patients whose day 91 after dialysis initiation fell between 1 January and 31 December 2002. Haemoglobin concentration, erythropoiesis-stimulating agent dose, comorbid condition and hospitalization data were obtained from Medicare claims. Patients were classified by 0, 1, 2 or 3 months with haemoglobin concentration below the K/DOQI target (11 g/dL). Using an inverse probability weighted marginal structural model to adjust for time-varying factors associated with haemoglobin concentration, we determined the association between number of months below target and subsequent risk for hospitalization and mortality.
The final cohort included 54 328 patients who met criteria. Those with more months below haemoglobin target were less likely to have received intravenous iron. More months below target were associated with increased risk of hospitalization (RR 1.70, 95% CI 1.63-1.76) and mortality (RR 2.48, 95% CI 2.28-2.69).
Future interventions should focus on modifiable factors associated with greater time below target haemoglobin concentrations to determine whether altering the time below target can alter the risk of hospitalizations or mortality.
一部分血液透析患者由于达到目标所需时间较长或血红蛋白水平波动,经历了低于目标血红蛋白水平的时期。我们旨在确定与低于目标血红蛋白浓度的累计月数相关的后果。
我们构建了一个发病队列,包括透析开始后第91天在2002年1月1日至12月31日之间的患者。血红蛋白浓度、促红细胞生成素剂量、合并症和住院数据来自医疗保险理赔记录。根据血红蛋白浓度低于K/DOQI目标(11 g/dL)的0、1、2或3个月对患者进行分类。使用逆概率加权边际结构模型来调整与血红蛋白浓度相关的随时间变化的因素,我们确定了低于目标的月数与随后住院和死亡风险之间的关联。
最终队列包括54328名符合标准的患者。血红蛋白低于目标的月数越多,接受静脉铁剂治疗的可能性越小。低于目标的月数越多,住院风险(RR 1.70,95% CI 1.63 - 1.76)和死亡风险(RR 2.48,95% CI 2.28 - 2.69)越高。
未来的干预措施应侧重于与低于目标血红蛋白浓度的时间更长相关的可改变因素,以确定改变低于目标的时间是否可以改变住院或死亡风险。